Janus Henderson Group PLC 23and Me Holding Co. Transaction History

Janus Henderson Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.4 - $0.91 $24 - $54	-60 Reduced 0.04%	142,207 $75,000
Q4 2023 Feb 14, 2024	BUY	$0.71 - $0.97 $4 - $5	6 Added 0.0%	142,267 $129,000
Q3 2023 Nov 14, 2023	BUY	$0.96 - $2.01 $0 - $2	1 Added 0.0%	142,261 $139,000
Q2 2023 Aug 14, 2023	BUY	$1.59 - $2.29 $124,822 - $179,776	78,505 Added 123.14%	142,260 $248,000
Q1 2023 May 15, 2023	BUY	$2.05 - $2.87 $54,390 - $76,146	26,532 Added 71.28%	63,755 $145,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.12 $811 - $1,597	312 Added 0.85%	37,223 $106,000
Q2 2022 Aug 15, 2022	BUY	$2.19 - $3.98 $80,835 - $146,905	36,911 New	36,911 $92,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $823M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.